vs

Side-by-side financial comparison of PC CONNECTION INC (CNXN) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

PC CONNECTION INC is the larger business by last-quarter revenue ($702.9M vs $622.0M, roughly 1.1× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 2.9%, a 31.5% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -0.8%). Over the past eight quarters, PC CONNECTION INC's revenue compounded faster (5.5% CAGR vs 4.6%).

PC Connection, Inc., doing business as Connection, is headquartered in Merrimack, New Hampshire. It has more than 2,600 employees and sells more than 460,000 products.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

CNXN vs RPRX — Head-to-Head

Bigger by revenue
CNXN
CNXN
1.1× larger
CNXN
$702.9M
$622.0M
RPRX
Growing faster (revenue YoY)
RPRX
RPRX
+5.6% gap
RPRX
4.8%
-0.8%
CNXN
Higher net margin
RPRX
RPRX
31.5% more per $
RPRX
34.4%
2.9%
CNXN
Faster 2-yr revenue CAGR
CNXN
CNXN
Annualised
CNXN
5.5%
4.6%
RPRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNXN
CNXN
RPRX
RPRX
Revenue
$702.9M
$622.0M
Net Profit
$20.7M
$214.2M
Gross Margin
19.3%
Operating Margin
3.4%
62.4%
Net Margin
2.9%
34.4%
Revenue YoY
-0.8%
4.8%
Net Profit YoY
-0.0%
2.9%
EPS (diluted)
$0.82
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNXN
CNXN
RPRX
RPRX
Q4 25
$702.9M
$622.0M
Q3 25
$709.1M
$609.3M
Q2 25
$759.7M
$578.7M
Q1 25
$701.0M
$568.2M
Q4 24
$708.9M
$593.6M
Q3 24
$724.7M
$564.7M
Q2 24
$736.5M
$537.3M
Q1 24
$632.0M
$568.0M
Net Profit
CNXN
CNXN
RPRX
RPRX
Q4 25
$20.7M
$214.2M
Q3 25
$24.7M
$288.2M
Q2 25
$24.8M
$30.2M
Q1 25
$13.5M
$238.3M
Q4 24
$20.7M
$208.2M
Q3 24
$27.1M
$544.0M
Q2 24
$26.2M
$102.0M
Q1 24
$13.2M
$4.8M
Gross Margin
CNXN
CNXN
RPRX
RPRX
Q4 25
19.3%
Q3 25
19.6%
Q2 25
18.1%
Q1 25
18.2%
Q4 24
18.3%
Q3 24
18.7%
Q2 24
18.5%
Q1 24
18.7%
Operating Margin
CNXN
CNXN
RPRX
RPRX
Q4 25
3.4%
62.4%
Q3 25
4.3%
70.1%
Q2 25
4.1%
36.3%
Q1 25
2.1%
94.0%
Q4 24
3.2%
60.9%
Q3 24
4.1%
Q2 24
4.2%
50.2%
Q1 24
2.1%
-13.0%
Net Margin
CNXN
CNXN
RPRX
RPRX
Q4 25
2.9%
34.4%
Q3 25
3.5%
47.3%
Q2 25
3.3%
5.2%
Q1 25
1.9%
41.9%
Q4 24
2.9%
35.1%
Q3 24
3.7%
96.3%
Q2 24
3.6%
19.0%
Q1 24
2.1%
0.8%
EPS (diluted)
CNXN
CNXN
RPRX
RPRX
Q4 25
$0.82
$0.49
Q3 25
$0.97
$0.67
Q2 25
$0.97
$0.07
Q1 25
$0.51
$0.55
Q4 24
$0.78
$0.46
Q3 24
$1.02
$1.21
Q2 24
$0.99
$0.23
Q1 24
$0.50
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNXN
CNXN
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$406.7M
$618.7M
Total DebtLower is stronger
$9.0B
Stockholders' EquityBook value
$910.1M
$9.7B
Total Assets
$1.4B
$19.6B
Debt / EquityLower = less leverage
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNXN
CNXN
RPRX
RPRX
Q4 25
$406.7M
$618.7M
Q3 25
$399.2M
$938.9M
Q2 25
$346.1M
$631.9M
Q1 25
$340.3M
$1.1B
Q4 24
$442.6M
$929.0M
Q3 24
$429.1M
$950.1M
Q2 24
$385.8M
$1.8B
Q1 24
$352.0M
$843.0M
Total Debt
CNXN
CNXN
RPRX
RPRX
Q4 25
$9.0B
Q3 25
$8.9B
Q2 25
$8.0B
Q1 25
$7.6B
Q4 24
$7.6B
Q3 24
$7.6B
Q2 24
$7.6B
Q1 24
$6.1B
Stockholders' Equity
CNXN
CNXN
RPRX
RPRX
Q4 25
$910.1M
$9.7B
Q3 25
$902.7M
$9.6B
Q2 25
$884.8M
$9.5B
Q1 25
$877.0M
$9.8B
Q4 24
$911.0M
$10.3B
Q3 24
$897.4M
$10.3B
Q2 24
$874.9M
$9.8B
Q1 24
$852.7M
$9.9B
Total Assets
CNXN
CNXN
RPRX
RPRX
Q4 25
$1.4B
$19.6B
Q3 25
$1.3B
$19.3B
Q2 25
$1.3B
$18.3B
Q1 25
$1.2B
$17.6B
Q4 24
$1.3B
$18.2B
Q3 24
$1.3B
$18.0B
Q2 24
$1.3B
$17.7B
Q1 24
$1.2B
$16.1B
Debt / Equity
CNXN
CNXN
RPRX
RPRX
Q4 25
0.92×
Q3 25
0.93×
Q2 25
0.84×
Q1 25
0.78×
Q4 24
0.74×
Q3 24
0.74×
Q2 24
0.78×
Q1 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNXN
CNXN
RPRX
RPRX
Operating Cash FlowLast quarter
$27.4M
$827.1M
Free Cash FlowOCF − Capex
$25.2M
FCF MarginFCF / Revenue
3.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
1.32×
3.86×
TTM Free Cash FlowTrailing 4 quarters
$58.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNXN
CNXN
RPRX
RPRX
Q4 25
$27.4M
$827.1M
Q3 25
$64.1M
$702.6M
Q2 25
$26.3M
$364.0M
Q1 25
$-52.4M
$596.1M
Q4 24
$25.2M
$742.5M
Q3 24
$52.9M
$703.6M
Q2 24
$38.4M
$658.2M
Q1 24
$57.3M
$664.6M
Free Cash Flow
CNXN
CNXN
RPRX
RPRX
Q4 25
$25.2M
Q3 25
$62.3M
Q2 25
$24.6M
Q1 25
$-54.1M
Q4 24
$22.9M
Q3 24
$51.2M
Q2 24
$36.6M
Q1 24
$55.7M
FCF Margin
CNXN
CNXN
RPRX
RPRX
Q4 25
3.6%
Q3 25
8.8%
Q2 25
3.2%
Q1 25
-7.7%
Q4 24
3.2%
Q3 24
7.1%
Q2 24
5.0%
Q1 24
8.8%
Capex Intensity
CNXN
CNXN
RPRX
RPRX
Q4 25
0.3%
Q3 25
0.3%
Q2 25
0.2%
Q1 25
0.2%
Q4 24
0.3%
Q3 24
0.2%
Q2 24
0.2%
Q1 24
0.3%
Cash Conversion
CNXN
CNXN
RPRX
RPRX
Q4 25
1.32×
3.86×
Q3 25
2.59×
2.44×
Q2 25
1.06×
12.06×
Q1 25
-3.89×
2.50×
Q4 24
1.22×
3.57×
Q3 24
1.96×
1.29×
Q2 24
1.47×
6.45×
Q1 24
4.35×
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNXN
CNXN

Small And Medium Sized Businesses Segment$273.5M39%
Notebooks And Mobility$108.6M15%
Public Sector$90.8M13%
Accessories$46.4M7%
Desktops$44.5M6%
Displays And Sounds$37.1M5%
Software$32.3M5%
Other Hardware And Services$30.7M4%
Net And Com$21.4M3%
Servers And Storage$17.6M3%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons